1,4-dioxane has been researched along with Experimental Hepatoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burleigh-Flayer, H; Crum, J; Dourson, ML; Forsberg, ND; Higginbotham, J; Lafranconi, M; Nance, P; Reichard, J | 1 |
Furihata, C; Ogawa, K; Suzuki, T; Toyoda, T | 1 |
Andersen, ME; Gargas, ML; McCroskey, PS; Park, CN; Reitz, RH | 1 |
3 other study(ies) available for 1,4-dioxane and Experimental Hepatoma
Article | Year |
---|---|
Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane.
Topics: Animals; Dioxanes; Hyperplasia; Liver; Liver Neoplasms, Experimental; Liver Regeneration; Mice; Mutagens; Rats; Risk Assessment; Species Specificity | 2017 |
Using RNA-Seq with 11 marker genes to evaluate 1,4-dioxane compared with typical genotoxic and non-genotoxic rat hepatocarcinogens.
Topics: Animals; Biomarkers, Tumor; Carcinogenesis; Carcinogens; Dioxanes; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344 | 2018 |
Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane.
Topics: Animals; Carcinogens, Environmental; Computer Simulation; Dioxanes; Dioxins; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Models, Biological; Rats; Risk; Solubility | 1990 |